Find a clinical trial

Search for clinical trials in your area or further afield. We recommend speaking to your medical team if you find a trial you think you may be eligible for.

miles of
A woman with ovarian cancer wearing a coat and green jumper walking down a hospital corridor

ARIEL 4: A study of rucaparib versus chemotherapy in BRCA positive ovarian cancer

The aim of the trial is to fully understand the benefits of a PARP inhibitor versus standard chemotherapy for BRCA-positive women who have had two previous treatments. Drugs involved in this trial: rucaparib, a PARP inhibitor paclitaxel, a standard chemotherapy drug carboplatin or cisplatin, standard chemotherapy drugs. Women in t…

A woman talks to her husband whilst having chemotherapy

ATHENA: A trial looking at the effectiveness of using a combination of a PARP inhibitor (rucaparib) and an anti-PD-1 inhibitor (nivolumab) after initial chemotherapy in preventing cancer growth or recurrence

This trial looks to answer the question as to whether two different types of anti-cancer drugs, given as maintenance treatment are: safe effective well-tolerated. Maintenance treatment refers to drugs that are given to try to slow or prevent or delay the cancer's return after it has responded to chemotherapy. There are three dru…

Close up of a woman looking at Target Ovarian Cancer's website on her phone during chemotherapy

CEBOC: A study into the safety of cediranib in the prevention of bowel perforation

The main purpose of conducting the trial is to: determine the safety of combining cediranib, a VEGF inhibitor, with paclitaxel a weekly chemotherapy regime find out how well the treatment works in terms of shrinking the cancer and preventing bowel obstruction. If the cancer responds to this treatment then after the course of paclitaxel…

Close up of a woman scrolling through Target Ovarian Cancer's website on her phone during chemotherapy

DICE: A trial of TAK228 and weekly paclitaxel chemotherapy versus weekly paclitaxel alone in advanced/recurrent ovarian cancer

This study is looking at using a new drug called TAK228 (new drug) in combination with paclitaxel (a chemotherapy drug) to see if it is a more effective way of treating ovarian cancer. If you were to take part in this trial you would be randomised to receive either paclitaxel on its own or paclitaxel and TAK228. You would be monitored throughout…